Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cannabis cancer:

Cannabis in cancer care. Abrams DI et al. Clin Pharmacol Ther. (2015)

Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. Gurney J et al. BMC Cancer. (2015)

Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. Zhang LR et al. Int J Cancer. (2015)

Search results

Items: 1 to 20 of 543

1.

Negative affectivity as a mechanism underlying perceived distress tolerance and cannabis use problems, barriers to cessation, and self-efficacy for quitting among urban cannabis users.

Manning K, Paulus DJ, Hogan JBD, Buckner JD, Farris SG, Zvolensky MJ.

Addict Behav. 2017 Nov 28;78:216-222. doi: 10.1016/j.addbeh.2017.11.041. [Epub ahead of print]

PMID:
29216571
2.

Cannabis and Cannabinoids (PDQ®): Health Professional Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2017 Nov 30.

3.

Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status.

Ramo DE, Bahorik AL, Delucchi KL, Campbell CI, Satre DD.

J Psychoactive Drugs. 2017 Dec 4:1-11. doi: 10.1080/02791072.2017.1401185. [Epub ahead of print]

PMID:
29199899
4.

A scoping review and meta-analysis of psychosocial and pharmacological treatments for cannabis and tobacco use among African Americans.

Montgomery L, Robinson C, Seaman EL, Haeny AM.

Psychol Addict Behav. 2017 Dec;31(8):922-943. doi: 10.1037/adb0000326.

PMID:
29199844
5.

Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.

Lötsch J, Weyer-Menkhoff I, Tegeder I.

Eur J Pain. 2017 Nov 21. doi: 10.1002/ejp.1148. [Epub ahead of print] Review.

PMID:
29160600
6.

Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies.

O'Hearn S, Diaz P, Wan BA, DeAngelis C, Lao N, Malek L, Chow E, Blake A.

Ann Palliat Med. 2017 Aug 31. pii: apm.2017.08.04. doi: 10.21037/apm.2017.08.04. [Epub ahead of print]

7.

Standardized <i>Cannabis sativa</i> extract attenuates tau and stathmin gene expression in the melanoma cell line.

Vaseghi G, Taki MJ, Javanmard SH.

Iran J Basic Med Sci. 2017 Oct;20(10):1178-1181. doi: 10.22038/IJBMS.2017.9398.

8.

[Cannabis and lung. What we know and everything we don't know yet].

Urban T, Hureaux J.

Rev Pneumol Clin. 2017 Dec;73(6):283-289. doi: 10.1016/j.pneumo.2017.08.013. Epub 2017 Nov 8. Review. French.

PMID:
29126755
9.

[Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].

Amato L, Minozzi S, Mitrova Z, Parmelli E, Saulle R, Cruciani F, Vecchi S, Davoli M.

Epidemiol Prev. 2017 Sep-Dec;41(5-6):279-293. doi: 10.19191/EP17.5-6.AD01.069. Review. Italian.

10.

Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation.

Zgair A, Lee JB, Wong JCM, Taha DA, Aram J, Di Virgilio D, McArthur JW, Cheng YK, Hennig IM, Barrett DA, Fischer PM, Constantinescu CS, Gershkovich P.

Sci Rep. 2017 Nov 6;7(1):14542. doi: 10.1038/s41598-017-15026-z.

11.

Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011.

Callaghan RC, Allebeck P, Akre O, McGlynn KA, Sidorchuk A.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1644-1652. doi: 10.1158/1055-9965.EPI-17-0428.

PMID:
29093004
12.

Substance abuse and cancer.

Moussas GI, Papadopoulou AG.

Psychiatriki. 2017 Jul-Sep;28(3):234-241. doi: 10.22365/jpsych.2017.283.234.

PMID:
29072187
13.

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.

Soderstrom K, Soliman E, Van Dross R.

Front Pharmacol. 2017 Oct 10;8:720. doi: 10.3389/fphar.2017.00720. eCollection 2017. Review.

14.

The Risks and Benefits of Cannabis in the Dermatology Clinic.

Dhadwal G, Kirchhof MG.

J Cutan Med Surg. 2017 Oct 1:1203475417738971. doi: 10.1177/1203475417738971. [Epub ahead of print]

PMID:
29056081
15.

Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.

Häuser W, Petzke F, Fitzcharles MA.

Eur J Pain. 2017 Oct 15. doi: 10.1002/ejp.1118. [Epub ahead of print] Review.

PMID:
29034533
16.

Cannabinoids in Pain Management and Palliative Medicine.

Häuser W, Fitzcharles MA, Radbruch L, Petzke F.

Dtsch Arztebl Int. 2017 Sep 22;114(38):627-634. doi: 10.3238/arztebl.2017.0627.

17.

The use of cannabis in response to the opioid crisis: A review of the literature.

Vyas MB, LeBaron VT, Gilson AM.

Nurs Outlook. 2017 Sep 21. pii: S0029-6554(17)30286-5. doi: 10.1016/j.outlook.2017.08.012. [Epub ahead of print]

PMID:
28993073
18.

Cannabis and Cannabinoids for Chronic Pain.

Romero-Sandoval EA, Kolano AL, Alvarado-Vázquez PA.

Curr Rheumatol Rep. 2017 Oct 5;19(11):67. doi: 10.1007/s11926-017-0693-1. Review.

PMID:
28983880
19.

The Use of Substances Other Than Nicotine in Electronic Cigarettes Among College Students.

Kenne DR, Fischbein RL, Tan AS, Banks M.

Subst Abuse. 2017 Sep 25;11:1178221817733736. doi: 10.1177/1178221817733736. eCollection 2017.

20.

Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids.

Ngwa W, Kumar R, Moreau M, Dabney R, Herman A.

Front Oncol. 2017 Sep 19;7:208. doi: 10.3389/fonc.2017.00208. eCollection 2017.

Supplemental Content

Loading ...
Support Center